Evaluation of pulmonary complications in patients with primary immunodeficiency disorders.
Mohsen Reisi(Isfahan University of Medical Sciences), Asghar Aghamohammadi(Amirkabir University of Technology), Naiimeh Tavakolinia(Universal Scientific Education and Research Network), Farzad Masiha(Children's Medical Center), Rohola Shirzadi(Children's Medical Center), Hosein Rafiemanesh(Shahid Beheshti University of Medical Sciences), Gholamreza Azizi(Jefferson Hospital for Neuroscience), Tooba Momen, Mohammadreza Modaresi(Children's Medical Center), Fatemeh Kiaee(University of Tehran)
PubMed
May 1, 2017
Cited by 23
Related Papers
Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach
|International Immunopharmacology|2022|384
Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment
|Frontiers in Immunology|2022|363
Coronavirus disease 2019 (COVID‐19): An overview of the immunopathology, serological diagnosis and management
|Scandinavian Journal of Immunology|2020|339
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
Primary immunodeficiency and autoimmunity: A comprehensive review
|Journal of Autoimmunity|2019|239